Single-Cell Transcriptomic Drug Repurposing in Multiple Sclerosis Cerebrospinal Fluid Identifies Novel Candidates Including IPI-145, LXR-623, and MDM2 Inhibitors
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 21 March 2026
- Language
- EN
- Document type
- Preprint